IHCH-3064 - CAS 2420562-65-6

IHCH-3064 is a tumour immunotherapeutic agent that targets both the adenosine A2A receptor and HDAC. IHCH-3064 effectively binds A2AR (Ki: 2.2 nM) and selectively inhibits HDAC1 (IC50: 80.2 nM) . Prexasertib Mesylate

Others, Adenosine Receptor, HDAC

Neuroscience, Chromatin/Epigenetic, GPCR/G Protein, Others, DNA Damage/DNA Repair

2420491

C25H21N9O2

479.49

NC=1N2C(C3=C(N(CCC4=CC=C(C(NC5=C(N)C=CC=C5)=O)C=C4)N=C3)N1)=NC(=N2)C6=CC=CO6

-20°C

Ice Packs

Small Compound